Sat. Jun 19th, 2021

Duchenne muscular dystrophy is an inherited disorder found in mostly in male children that leads to abnormality in walking, difficulty in standing and muscle weakness. However, a female child can be also be affected but the severity is low due to low expression X allele chromosome.   Increase in the incidence of Duchenne Muscular Dystrophy globally will drive the market due to growing demand for the disease diagnosis.  For instance, In U.S., an estimated prevalence of Duchenne muscular dystrophies is around 250,000 individuals, which have led to increasing in the diagnosis need for disease detection.  However, limited availability and testing procedures limits the growth of the market. Leading companies operating in diseases testing market can find this as lucrative opportunity to invest in bring new kits and diagnosis procedures for effective diagnosis of Duchenne Muscular Dystrophy.

Get Sample Copy of the Report @

Duchenne Muscular Dystrophy Testing Market: Drivers and Restraints

Till now there is non- availability of treatment for Duchenne muscular dystrophy. However, new developments on early disease diagnosis and detection can help physicians in prescribing preventing measures for Duchenne Muscular Dystrophy. This can help in controlling abnormality that is frequent to this disease. With disease being more common in male child, it bring new opportunities for manufacturers to invest in R&D especially in investigating in chromosomal mutations responsible for disease outbreak.  .  For example, the global prevalence of Duchenne muscular dystrophy is estimated to be 1 male for 3,500 live male births and moist common in age group of 1-6 years. An increasing in number of Duchenne muscular dystrophy patient population is anticipated drive the Duchenne muscular dystrophy testing market. With increase in diagnosis research focused towards Duchenne muscular dystrophy, it will generate new avenues and opportunities for key players to have lucrative share in Duchenne muscular dystrophy testing market with new testing product launch. However, as sequencing is an integral part in Duchenne muscular dystrophy diagnosis test, it leads to increase the overall cost of diagnosis. For low income countries, the diagnosis becomes unaffordable. For instance, Duchenne muscular dystrophy testing can range from about $100 to more than $2,000, depending on type and complexity and with NGS segueing in it, the rates can even go more higher in certain cases.  With favorable reimbursement policies, countries in North America and Europe are anticipated to boost the market of Duchenne muscular dystrophy testing to grow in the forecasting period.

Duchene Muscular Dystrophy Testing MarketSegmentation

Based on product type, Duchene Muscular Dystrophy Testing market is segmented into following:

  • Instruments
    • NGS Workstations
    • Other Devices
  • Kits & Regants
    • GSP Neonatal Creatine Kinase-MM kits
    • Chemicals & Reagents
    • Others

Based on Test type, Duchene Muscular Dystrophy Testing market is segmented into following:

  • Electromyography Test
  • Genetic Test
  • Blood Enzyme Test

Based on Technology, Duchene Muscular Dystrophy Testing market is segmented into following:

  • Multiplex ligation-dependent probe amplification
  • Ion Torrent next-generation sequencing

Based on End User, Duchene Muscular Dystrophy Testing market is segmented into following

  • Hospitals
  • Clinics
  • Diagnostic laboratories
  • Clinical Research Organizations (CROs)

Duchenne Muscular Dystrophy Testing Market: Overview

The growth of Duchenne muscular dystrophy testing market will increase due to increase in disease burden of Duchenne muscular dystrophy. Based on product type, Duchene Muscular Dystrophy Testing market has been segmented into Instruments and kits and reagents. Based on test type, Duchene Muscular Dystrophy Testing market has been segmented into Electromyography Test, Genetic Test and Blood Enzyme Test. Based on Technology, Duchene Muscular Dystrophy Testing market has been segmented into Multiplex ligation-dependent probe amplification and Ion Torrent next-generation sequencing.

Duchenne Muscular Dystrophy Testing MarketRegional Overview

Based on geography, the global Duchenne Muscular Dystrophy Testing market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is expected to show significant growth for global Duchenne Muscular Dystrophy Testing market due to rising prevalence of Duchenne Muscular Dystrophy and availability of well-developed healthcare infrastructure. Likewise, Europe is also projected to be second largest market for Duchenne Muscular Dystrophy Testing due to increasing prevalence of the disease in the region. Besides, enhanced healthcare infrastructure and increased R&D expenditure on diseases diagnosis is also going to fuel the market growth. In terms of highest market growth, Asia-Pacific is expected to lead the Duchenne Muscular Dystrophy Testing market.

Duchenne Muscular Dystrophy Testing Market: Key players

Some of the key players present in global Duchenne muscular dystrophy testing market is Invitae, PerkinElmer, Inc., and others. Based on product type Duchene Muscular Dystrophy Testing market

The report covers exhaust analysis on Duchenne Muscular Dystrophy Testing Market:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The report on Duchenne Muscular Dystrophy Testing Market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report on Duchenne Muscular Dystrophy Testing Market highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Request TOC of the Report @

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

By ajinkya